Skip to content

Evaluating effect of Rasa sinex on treatment of allergic rhinitis in children in pediatric clinic in Qom (2019-2020)

Evaluating effect of Rasa sinex on treatment of allergic rhinitis in children in pediatric clinic in Qom (2019-2020)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20211011001
Enrollment
100
Registered
2021-10-11
Start date
2019-09-23
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Rhinitis Nasal congestion rhinorrhea sneezing snoring at night itchy throat

Interventions

the intervention group received oral antihistamine treatment with Rasa sinx nasal spray,The control group received oral antihistamine treatment with placebo
Experimental Drug,Placebo Comparator Drug
intervention group,control group

Sponsors

Qom Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 16 Years

Inclusion criteria

Inclusion criteria: Allergic rhinitis Satisfaction to participate in the study Taking prescription drugs for 4 weeks Age over one year

Exclusion criteria

Exclusion criteria: 1) The presence of any disease or associated abnormality, including: the presence of nasal polyps, the presence of nasal septal deviation, asthma and lung diseases and infectious sinusitis, and any infection in the respiratory tract, etc. 2) Age less than one year 3) Dissatisfaction with participating in the study

Design outcomes

Primary

MeasureTime frame
Illness severity 4 weeks after interention mild,moderate,severe/ based on checklist of symptopms that we used

Secondary

MeasureTime frame
Duration of illness 4 weks after intervention days/how many days after intervention patients had symptoms of allergic rhinitis

Countries

Iran

Contacts

Public Contactzahra sadat hosseini

Qom iaslamic azad university

zaahraahsn@gmail.com00989367230974

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026